<DOC>
	<DOCNO>NCT01127308</DOCNO>
	<brief_summary>This single dose study radiolabeled [ 14C ] -ertugliflozin ( PF04971729 , MK-8835 ) healthy male volunteer study absorption , distribution , metabolism elimination ertugliflozin .</brief_summary>
	<brief_title>A Radiolabeled Mass Balance Study 14C-Ertugliflozin ( PF04971729 , MK-8835 ) In Healthy Male Participants ( MK-8835-038 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male participant Body Mass Index 17.5 30.5 kg/m2 total body weight &gt; 50 kg ( 110 lb ) Female participant . Participants enrol previous radionucleotide study receive radiotherapy expose significant radiation within 12 month prior screen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Absorption</keyword>
	<keyword>Distribution</keyword>
	<keyword>Metabolism</keyword>
	<keyword>Excretion</keyword>
	<keyword>Mass Balance</keyword>
	<keyword>Metabolic Profile</keyword>
	<keyword>Radiolabel Study</keyword>
</DOC>